Published in Value Health on July 24, 2008
Striding out with Parkinson disease: evidence-based physical therapy for gait disorders. Phys Ther (2009) 1.31
Adherence to a Mediterranean diet is associated with a better health-related quality of life: a possible role of high dietary antioxidant content. BMJ Open (2013) 0.99
Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS One (2012) 0.94
Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries. Qual Life Res (2009) 0.91
Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis (2011) 0.87
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J Neurol (2013) 0.84
A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease. Front Hum Neurosci (2015) 0.83
Health-related quality of life and strain in caregivers of Australians with Parkinson's disease: an observational study. BMC Neurol (2012) 0.82
Cognitive decline and quality of life in incident Parkinson's disease: The role of attention. Parkinsonism Relat Disord (2016) 0.82
Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease? Aging Dis (2013) 0.79
Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease. Health Qual Life Outcomes (2011) 0.76
Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment. Front Behav Neurosci (2015) 0.76
Health-related quality of life in Parkinson's disease patients in northeastern Sicily, Italy: (An ecological perspective). Neural Regen Res (2013) 0.75
Motor and Non-Motor Symptoms in Parkinson's Disease: Effects on Quality of Life. Noro Psikiyatr Ars (2016) 0.75
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord (2002) 2.23
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain (2009) 2.22
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. Eur J Pain (2009) 2.12
Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain (2010) 2.07
Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord (2006) 1.57
Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord (2004) 1.48
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol (2011) 1.45
Development of a symptoms questionnaire for complex regional pain syndrome and potentially related illnesses: the Trauma Related Neuronal Dysfunction Symptoms Inventory. Arch Phys Med Rehabil (2008) 1.44
Importance of nondopaminergic features in evaluating disease severity of Parkinson disease. Neurology (2014) 1.43
Short-term menopausal hormone therapy for symptom relief: an updated decision model. Arch Intern Med (2004) 1.42
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord (2009) 1.36
The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord (2010) 1.34
Clarifying values: an updated review. BMC Med Inform Decis Mak (2013) 1.22
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology (2013) 1.20
Complex regional pain syndrome 1--the Swiss cohort study. BMC Musculoskelet Disord (2008) 1.19
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Clinical subtypes of Parkinson's disease. Mov Disord (2010) 1.18
Different formats for communicating surgical risks to patients and the effect on choice of treatment. Patient Educ Couns (2004) 1.17
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord (2010) 1.09
Clinical tests for the evaluation of postural instability in patients with parkinson's disease. Arch Phys Med Rehabil (2003) 1.07
Thinking about movement hurts: the effect of motor imagery on pain and swelling in people with chronic arm pain. Arthritis Rheum (2008) 1.04
Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry (2011) 1.03
Development of a severity score for CRPS. Pain (2010) 1.02
Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord (2008) 1.01
The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus (2013) 1.01
Spreading of complex regional pain syndrome: not a random process. J Neural Transm (Vienna) (2011) 0.97
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease. Mov Disord (2008) 0.95
The influence of gender on phenotype and disease progression in patients with Huntington's disease. Parkinsonism Relat Disord (2012) 0.94
Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia. Clin J Pain (2008) 0.91
HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia. Pain (2009) 0.91
Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease. Mov Disord (2011) 0.90
Physiotherapy in Parkinson's disease: utilisation and patient satisfaction. J Neurol (2004) 0.90
Motor patterns in Parkinson's disease: a data-driven approach. Mov Disord (2009) 0.90
Posterior lumbar interbody fusion with stand-alone Trabecular Metal cages for repeatedly recurrent lumbar disc herniation and back pain. J Neurosurg Spine (2014) 0.89
Onset and progression of dystonia in complex regional pain syndrome. Pain (2007) 0.88
Diagnostic criteria for CRPS I: differences between patient profiles using three different diagnostic sets. Eur J Pain (2007) 0.88
Peripheral trauma and movement disorders. Parkinsonism Relat Disord (2007) 0.87
Spontaneous onset of complex regional pain syndrome. Eur J Pain (2009) 0.85
Assessing comorbidity in patients with Parkinson's disease. Mov Disord (2004) 0.84
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord (2008) 0.84
Shared decision making in the Netherlands, is the time ripe for nationwide, structural implementation? Z Evid Fortbild Qual Gesundhwes (2011) 0.83
Surgery versus prolonged conservative treatment for sciatica: 5-year results of a randomised controlled trial. BMJ Open (2013) 0.83
Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. Mov Disord (2013) 0.83
Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease. Mov Disord (2013) 0.82
Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC. Mov Disord (2007) 0.82
Familial occurrence of complex regional pain syndrome. Eur J Pain (2008) 0.81
Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain (2012) 0.81
Fixed dystonia in complex regional pain syndrome: a descriptive and computational modeling approach. BMC Neurol (2011) 0.81
Relation of clinical subtypes in Parkinson's disease with survival. Mov Disord (2013) 0.81
Increased risk of complex regional pain syndrome in siblings of patients? J Pain (2009) 0.81
Motor dysfunction of complex regional pain syndrome is related to impaired central processing of proprioceptive information. J Pain (2013) 0.80
Distribution of signs and symptoms of complex regional pain syndrome type I in patients meeting the diagnostic criteria of the International Association for the Study of Pain. Eur J Pain (2011) 0.80
SCOPA-cognition cutoff value for detection of Parkinson's disease dementia. Mov Disord (2011) 0.79
Psychotic and compulsive symptoms in Parkinson's disease. Mov Disord (2009) 0.79
Systematic mutation analysis of seven dystonia genes in complex regional pain syndrome with fixed dystonia. J Neurol (2010) 0.77
The Huntington's Disease Dysphagia Scale. Mov Disord (2014) 0.77
Spinal axis imaging in non-aneurysmal subarachnoid hemorrhage: a prospective cohort study. J Neurol (2014) 0.77
Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay. J Neurol (2013) 0.77
Psychological features of patients with complex regional pain syndrome type I related dystonia. Mov Disord (2008) 0.77
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology (2011) 0.77
Intrathecal glycine for pain and dystonia in complex regional pain syndrome. Pain (2009) 0.77
Efficacy of intrathecal baclofen on different pain qualities in complex regional pain syndrome. Anesth Analg (2012) 0.77
Postdural puncture headache in complex regional pain syndrome: a retrospective observational study. Pain Med (2009) 0.76
Thermal hypesthesia in patients with complex regional pain syndrome related dystonia. J Neural Transm (Vienna) (2010) 0.76
Thinking about the end of life: a common issue for patients with Huntington's disease. J Neurol (2014) 0.76
Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia. J Neural Transm (Vienna) (2014) 0.75
Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial. Trials (2013) 0.75
Translating the Dutch Walking Stairs, Walking Ability and Rising and Sitting Questionnaires into German and assessing their concurrent validity with VAS measures of pain and activities in daily living. BMC Musculoskelet Disord (2010) 0.75
German translation and external validation of the Radboud Skills Questionnaire in patients suffering from Complex Regional Pain Syndrome 1. BMC Musculoskelet Disord (2010) 0.75
Deficient muscle activation in patients with Complex Regional Pain Syndrome and abnormal hand postures: an electromyographic evaluation. Clin Neurophysiol (2013) 0.75
The lack of efficacy of different infusion rates of intrathecal baclofen in complex regional pain syndrome: a randomized, double-blind, crossover study. Pain Med (2011) 0.75
Reliability and validity of the range of motion scale (ROMS) in patients with abnormal postures. Pain Med (2014) 0.75
Initial experiences with endoscopic rhino-neurosurgery in Amsterdam. Eur Arch Otorhinolaryngol (2013) 0.75
Muscle hyperalgesia correlates with motor function in complex regional pain syndrome type 1. J Pain (2013) 0.75
Reliability of cluster results for different types of time adjustments in complex disease research. Conf Proc IEEE Eng Med Biol Soc (2008) 0.75
Muscle hyperalgesia is widespread in patients with complex regional pain syndrome. Pain (2013) 0.75
Mutational analysis of TARDBP in Parkinson's disease. Neurobiol Aging (2012) 0.75
An explanatory study evaluating the muscle relaxant effects of intramuscular magnesium sulphate for dystonia in complex regional pain syndrome. J Pain (2013) 0.75
A prospective, multisite, international validation of the Complex Regional Pain Syndrome Severity Score. Pain (2017) 0.75